Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CJ.1.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XANNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EU.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JB.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBPNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.36NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.26.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.254NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.418NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.122NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.168NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.6 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.343NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19749.2South Korea
AY.4.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.25.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.409NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.83NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.310NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.162NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Y.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.353NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.407NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.182NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used